U-fast

Sepsis kills 11 million people worldwide each year and represents astronomical costs for healthcare services (€+8 billion). Every hour following sepsis, the risk of death increases by 7%; thus, after about twelve hours, the probability of death exceeds 80%. When an individual is affected by sepsis, very rapid intervention is necessary to increase chances of survival. However, current methods for identifying antibiotics (antibiograms) to administer to patients are very slow (24/48h). U-FAST is developing an ultra-rapid antibiogram that allows for identification of the antibiotic to administer to the patient within 30 minutes. This method enables targeted treatment that avoids antibiotic resistance (the ability of bacteria to resist the effects of antibiotics). Our technology has a significant impact, resulting in over 30,000 lives saved in France, relieved hospitals, and savings on healthcare expenses.